Moelis & Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Moelis & Company on September 17, 2024, regarding events occurring on September 13, 2024. The filing focuses on corporate governance changes, specifically the election of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is not a financial statement filing and contains no operational financial data.
Material Changes
The primary material change reported is the election of Louise Mirrer as a director of the Company. Dr. Mirrer's term began on September 17, 2024. The Board has determined that Dr. Mirrer is "independent" under NYSE listing rules and Rule 10A-3 of the Securities Exchange Act.
Compensation and Governance Details
- Annual Compensation: Dr. Mirrer is eligible to receive $200,000 annually as a non-employee director.
- Compensation Structure:
- $100,000 in cash, Class A common stock, or a combination thereof at her option.
- $100,000 in Restricted Stock Units (RSUs) that vest upon grant and settle following the second anniversary of the grant (with the initial grant settling no later than 60 days from July 1, 2026).
- Expenses: The Company reimburses non-employee directors for expenses incurred attending Board and committee meetings.
- Indemnification: An indemnification agreement was entered into, substantially in the form attached to the Company's 2014 Form S-1 Registration Statement.
Investor Verification Checklist
- Verify the independence status of Dr. Mirrer against current NYSE listing standards.
- Review the attached press release (Exhibit 99.1) for additional context on Dr. Mirrer's background.
- Confirm the specific vesting and settlement terms of the RSUs in the definitive compensation agreement.
- Check subsequent filings for any changes to the Board composition or committee assignments.